The agency recommended that the researchers move forward with phase III trials, the final stage before potential approval of the drug. (scientificamerican.com)
Alexandris wrote that neither the FLSC nor the Ontario government has provided specific timelines on potential approvals but that Ryerson is «in an iterative process with both these bodies, obtaining questions and providing additional information and clarification, as needed, to the proposal.» (canadianlawyermag.com)
On June 11, a new prescription weight - loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. (sciencedaily.com)